Who Paid My Doc
James Del Rosso
MOHS-Micrographic Surgery Las Vegas, NV Doctor of Osteopathy
NPI 1083636369 CMS profile 3970
9097 W Post Rd Ste 100, Las Vegas, NV 89148
General payments
$3,612,246
Research payments
$5,105
Ownership & investment interest
$0
Research they led as principal investigator
$1,780,595
Through program year 2025, James Del Rosso of Las Vegas, NV is reported in the CMS Open Payments database as having received $3,612,246 across 2,581 general payments and $5,105 in research payments paid to them. Separately, studies naming them as principal investigator received $1,780,595 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of MOHS-Micrographic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $670,247 | 483 | |
| 2024 | General | $725,560 | 564 | |
| 2024 | Research | $105 | 1 | |
| 2023 | General | $739,887 | 508 | |
| 2022 | General | $550,256 | 390 | |
| 2021 | General | $281,823 | 195 | |
| 2021 | Research | $5,000 | 1 | |
| 2020 | General | $252,053 | 151 | |
| 2019 | General | $392,421 | 290 |
Beside peers
- James Del Rosso
- MOHS-Micrographic Surgery median
- Middle half of MOHS-Micrographic Surgery
- National median
In program year 2025, general payments to James Del Rosso were reported at $670,247. Among 1,077 MOHS-Micrographic Surgery profiles paid that year, the median was $465 and the middle half received between $145 and $1,066.
Show as a table
| Year | James Del Rosso | MOHS-Micrographic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $392,421 | $316 | $106–$785 | $163 |
| 2020 | $252,053 | $162 | $68–$412 | $114 |
| 2021 | $281,823 | $243 | $87–$654 | $132 |
| 2022 | $550,256 | $300 | $102–$887 | $149 |
| 2023 | $739,887 | $364 | $125–$1,010 | $160 |
| 2024 | $725,560 | $445 | $142–$1,108 | $164 |
| 2025 | $670,247 | $465 | $145–$1,066 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
2,583 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other MOHS-Micrographic Surgery in Nevada
Lucius Blanchard
MOHS-Micrographic Surgery · Las Vegas, NV
Grace Kim
MOHS-Micrographic Surgery · Las Vegas, NV
Mac MacHan
MOHS-Micrographic Surgery · Las Vegas, NV
Judy Doong
MOHS-Micrographic Surgery · Reno, NV
Douglas Thomas
MOHS-Micrographic Surgery · Las Vegas, NV
Whitney Call
MOHS-Micrographic Surgery · Henderson, NV
Related records
MOHS-Micrographic Surgery in Nevada
Practitioners in the same specialty and state, ranked by reported value.
All MOHS-Micrographic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Nevada
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.